3839 Stock Overview
Manufactures and sells chlortetracycline (CTC) and animal health products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Chia Tai Enterprises International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.50 |
52 Week High | HK$2.10 |
52 Week Low | HK$0.65 |
Beta | 3.15 |
1 Month Change | -14.29% |
3 Month Change | 85.19% |
1 Year Change | 78.57% |
3 Year Change | 7.14% |
5 Year Change | 1.35% |
Change since IPO | -73.73% |
Recent News & Updates
Recent updates
Chia Tai Enterprises International Limited (HKG:3839) Stock Rockets 30% But Many Are Still Ignoring The Company
Oct 02Chia Tai Enterprises International Limited (HKG:3839) Stock Rockets 28% But Many Are Still Ignoring The Company
May 29Not Many Are Piling Into Chia Tai Enterprises International Limited (HKG:3839) Just Yet
Feb 15Be Wary Of Chia Tai Enterprises International (HKG:3839) And Its Returns On Capital
Dec 21These 4 Measures Indicate That Chia Tai Enterprises International (HKG:3839) Is Using Debt Extensively
Oct 10Returns Are Gaining Momentum At Chia Tai Enterprises International (HKG:3839)
Aug 22Does Chia Tai Enterprises International (HKG:3839) Have A Healthy Balance Sheet?
Jun 07There's Been No Shortage Of Growth Recently For Chia Tai Enterprises International's (HKG:3839) Returns On Capital
Apr 17Chia Tai Enterprises International (HKG:3839) Seems To Use Debt Quite Sensibly
Jan 30We Think That There Are More Issues For Chia Tai Enterprises International (HKG:3839) Than Just Sluggish Earnings
Oct 05Chia Tai Enterprises International's (HKG:3839) Returns On Capital Not Reflecting Well On The Business
Jul 25Is Chia Tai Enterprises International (HKG:3839) A Risky Investment?
Jan 18Chia Tai Enterprises International (HKG:3839) Seems To Use Debt Quite Sensibly
Sep 08Does Chia Tai Enterprises International (HKG:3839) Have A Healthy Balance Sheet?
Apr 26The Returns At Chia Tai Enterprises International (HKG:3839) Provide Us With Signs Of What's To Come
Feb 28We Think Chia Tai Enterprises International (HKG:3839) Is Taking Some Risk With Its Debt
Jan 24Chia Tai Enterprises International's (HKG:3839) Stock Price Has Reduced 38% In The Past Five Years
Dec 02Shareholder Returns
3839 | HK Food | HK Market | |
---|---|---|---|
7D | -8.0% | -3.3% | -0.5% |
1Y | 78.6% | 1.9% | 19.9% |
Return vs Industry: 3839 exceeded the Hong Kong Food industry which returned 1.9% over the past year.
Return vs Market: 3839 exceeded the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
3839 volatility | |
---|---|
3839 Average Weekly Movement | 19.2% |
Food Industry Average Movement | 6.4% |
Market Average Movement | 8.8% |
10% most volatile stocks in HK Market | 18.6% |
10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 3839's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3839's weekly volatility has increased from 12% to 19% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 900 | n/a | www.ctei.com.hk |
Chia Tai Enterprises International Limited manufactures and sells chlortetracycline (CTC) and animal health products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates in two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brand names.
Chia Tai Enterprises International Limited Fundamentals Summary
3839 fundamental statistics | |
---|---|
Market cap | HK$361.08m |
Earnings (TTM) | HK$36.29m |
Revenue (TTM) | HK$1.73b |
10.0x
P/E Ratio0.2x
P/S RatioIs 3839 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3839 income statement (TTM) | |
---|---|
Revenue | US$223.02m |
Cost of Revenue | US$181.30m |
Gross Profit | US$41.72m |
Other Expenses | US$37.05m |
Earnings | US$4.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.019 |
Gross Margin | 18.71% |
Net Profit Margin | 2.09% |
Debt/Equity Ratio | 26.4% |
How did 3839 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 20:50 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chia Tai Enterprises International Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|